These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 18568033)

  • 1. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.
    Ehninger D; Han S; Shilyansky C; Zhou Y; Li W; Kwiatkowski DJ; Ramesh V; Silva AJ
    Nat Med; 2008 Aug; 14(8):843-8. PubMed ID: 18568033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
    Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
    Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
    Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
    Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.
    Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M
    J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
    Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
    Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex.
    Sato A; Kasai S; Kobayashi T; Takamatsu Y; Hino O; Ikeda K; Mizuguchi M
    Nat Commun; 2012; 3():1292. PubMed ID: 23250422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a region required for TSC1 stability by functional analysis of TSC1 missense mutations found in individuals with tuberous sclerosis complex.
    Mozaffari M; Hoogeveen-Westerveld M; Kwiatkowski D; Sampson J; Ekong R; Povey S; den Dunnen JT; van den Ouweland A; Halley D; Nellist M
    BMC Med Genet; 2009 Sep; 10():88. PubMed ID: 19747374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model.
    Mi R; Ma J; Zhang D; Li L; Zhang H
    J Genet Genomics; 2009 Jun; 36(6):355-61. PubMed ID: 19539245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice.
    Tsai PT; Hull C; Chu Y; Greene-Colozzi E; Sadowski AR; Leech JM; Steinberg J; Crawley JN; Regehr WG; Sahin M
    Nature; 2012 Aug; 488(7413):647-51. PubMed ID: 22763451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of Normal Cerebral Oxygen Consumption with Rapamycin Treatment in a Rat Model of Autism-Tuberous Sclerosis.
    Chi OZ; Wu CC; Liu X; Rah KH; Jacinto E; Weiss HR
    Neuromolecular Med; 2015 Sep; 17(3):305-13. PubMed ID: 26048361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation.
    Hwang SK; Lee JH; Yang JE; Lim CS; Lee JA; Lee YS; Lee K; Kaang BK
    Mol Brain; 2016 May; 9(1):56. PubMed ID: 27216612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterisation of the TSC1-TSC2 complex to assess multiple TSC2 variants identified in single families affected by tuberous sclerosis complex.
    Nellist M; Sancak O; Goedbloed M; Adriaans A; Wessels M; Maat-Kievit A; Baars M; Dommering C; van den Ouweland A; Halley D
    BMC Med Genet; 2008 Feb; 9():10. PubMed ID: 18302728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis.
    Ehninger D; Silva AJ
    Behav Genet; 2011 May; 41(3):357-63. PubMed ID: 20882401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tsc2 mutation rather than Tsc1 mutation dominantly causes a social deficit in a mouse model of tuberous sclerosis complex.
    Kashii H; Kasai S; Sato A; Hagino Y; Nishito Y; Kobayashi T; Hino O; Mizuguchi M; Ikeda K
    Hum Genomics; 2023 Feb; 17(1):4. PubMed ID: 36732866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brain proteomic investigation of rapamycin effects in the
    Wesseling H; Elgersma Y; Bahn S
    Mol Autism; 2017; 8():41. PubMed ID: 28775826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tsc1 haploinsufficiency in Nkx2.1 cells upregulates hippocampal interneuron mTORC1 activity, impairs pyramidal cell synaptic inhibition, and alters contextual fear discrimination and spatial working memory in mice.
    Haji N; Riebe I; Aguilar-Valles A; Artinian J; Laplante I; Lacaille JC
    Mol Autism; 2020 May; 11(1):29. PubMed ID: 32375878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis.
    Ehninger D; de Vries PJ; Silva AJ
    J Intellect Disabil Res; 2009 Oct; 53(10):838-51. PubMed ID: 19694899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis.
    Waltereit R; Welzl H; Dichgans J; Lipp HP; Schmidt WJ; Weller M
    J Neurochem; 2006 Jan; 96(2):407-13. PubMed ID: 16300636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reliable cell-based assay for testing unclassified TSC2 gene variants.
    Coevoets R; Arican S; Hoogeveen-Westerveld M; Simons E; van den Ouweland A; Halley D; Nellist M
    Eur J Hum Genet; 2009 Mar; 17(3):301-10. PubMed ID: 18854862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.